Obesity and Allometric Scaling of Pharmacokinetics

[1]  M. Danhof,et al.  Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients , 2011, Clinical pharmacokinetics.

[2]  J. Brodsky,et al.  Lean Body Weight Scalar for the Anesthetic Induction Dose of Propofol in Morbidly Obese Subjects , 2011, Anesthesia and analgesia.

[3]  H. Lemmens,et al.  Dose adjustment of anaesthetics in the morbidly obese. , 2010, British journal of anaesthesia.

[4]  M. Struys,et al.  Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. , 2010, British journal of anaesthesia.

[5]  H. Lemmens.  Perioperative pharmacology in morbid obesity , 2010, Current opinion in anaesthesiology.

[6]  D. Tibboel,et al.  Prediction of Propofol Clearance in Children from an Allometric Model Developed in Rats, Children and Adults versus a 0.75 Fixed-Exponent Allometric Model , 2010, Clinical pharmacokinetics.

[7]  E. V. van Dongen,et al.  Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study , 2010, European journal of anaesthesiology.

[8]  I. Fermo,et al.  No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients , 2009, European journal of anaesthesiology.

[9]  J. Coetzee.  Total intravenous anaesthesia to obese patients: largely guesswork? , 2009, European journal of anaesthesiology.

[10]  N. Holford,et al.  Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.

[11]  R. Farinotti,et al.  Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic Study , 1993, Anesthesiology.

[12]  Darrell R. Abernethy,et al.  Effect of Obesity on the Pharmacokinetics of Drugs in Humans , 2010, Clinical pharmacokinetics.

[13]  L. Colla,et al.  Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese , 2009, Clinical pharmacokinetics.

[14]  I. Fermo,et al.  Predictive performance of 'Servin's formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients. , 2007, British journal of anaesthesia.

[15]  M. Kleiber.  Body size and metabolism , 1932 .